Brigatinib/ceritinib
Tóm tắt
Từ khóa
Tài liệu tham khảo
Baglivo S, et al. Dramatic Response to Lorlatinib in a Heavily Pretreated Lung Adenocarcinoma Patient Harboring G1202R Mutation and a Synchronous Novel R1192P ALK Point Mutation. Journal of Thoracic Oncology 13: e145-e147, No. 8, Aug 2018. Available from: URL: http://doi.org/10.1016/j.jtho.2018.03.017 - Italy